Codes / ICD10CM / T37.1X6D

T37.1X6D Underdosing of antimycobacterial drugs, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Underdosing of antimycobacterial drugs, subsequent encounter

Summary

This condition refers to a subsequent encounter for underdosing of antimycobacterial medications, which are used to treat mycobacterial infections such as tuberculosis. It involves insufficient dosing of these agents during a follow-up visit, potentially affecting treatment efficacy or patient outcomes.

Causes

Underdosing may result from subtherapeutic dosing, patient non-adherence, formulation errors, or inadequate dosage adjustments during follow-up care. It can occur due to missed doses, incorrect administration, or failure to maintain therapeutic levels over time.

Risk Factors

  • Patient non-adherence to prescribed regimens.
  • Inadequate monitoring of drug levels or response.
  • Changes in renal or hepatic function affecting metabolism.
  • Concurrent medications altering drug absorption or efficacy.

Symptoms

  • Persistent or worsening infection signs (e.g., fever, cough, weight loss).
  • Treatment failure or delayed recovery.
  • Suboptimal therapeutic response to antimycobacterial therapy.
  • Potential for drug resistance development.

Diagnosis

Clinical evaluation focuses on medication history, adherence assessment, and lab tests (e.g., drug levels, infection markers). Follow-up imaging or cultures may confirm treatment response or resistance.

Treatment Options

Adjustments to dosing regimens, enhanced patient education, or alternative formulations may be considered. Close monitoring and adherence support are critical to optimize therapeutic outcomes.

Prognosis and Follow-Up

Prognosis depends on timely intervention and adherence. Regular follow-up ensures dosing adequacy and addresses any emerging issues to prevent complications or treatment failure.

Complications

  • Treatment failure or prolonged infection.
  • Development of drug-resistant strains.
  • Increased risk of adverse effects from prolonged therapy.
  • Potential for disease progression or recurrence.

Lifestyle & Prevention

  • Adherence to prescribed dosing schedules.
  • Use of reminder tools or support systems.
  • Regular communication with healthcare providers.
  • Education on medication importance and proper administration.

When to Seek Professional Help

Seek care if infection symptoms worsen, dosing issues arise, or treatment response is suboptimal. Prompt evaluation helps prevent complications or resistance.

Tips for Medical Coders

Document the encounter type (subsequent) and specify underdosing of antimycobacterial drugs. Include details on treatment adjustments, adherence challenges, or follow-up actions to support accurate coding.

Book a walkthrough

T37.1X6D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.